PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial - Si-Yang Maggie Liu; Jie Huang; Jia-Yi Deng; Chong-Rui Xu; Hong-Hong Yan; Ming-Yi Yang; Yang-Si Li; E-E Ke; Ming-Ying Zheng; Zhen Wang; Jia-Xin Lin; Bin Gan; et al. (Science Bulletin, 2024)